# Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study

> **NCT04170751** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 40 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** 16 mcg / cc of norepinephrine(group N)
- **DRUG:** 0.4 unit / cc of vasopressin(group V)

## Key facts

- **NCT ID:** NCT04170751
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-18
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04170751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04170751, "Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04170751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*